James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Why Twitter Inc. (TWTR), Mylan NV (MYL) and GrubHub Inc. (GRUB) Are 3 of Today’s Worst Stocks

Twitter (TWTR), Mylan (MYL) and GrubHub (GRUB) got the new week started on the wrong foot. Here's what investors need to know.

The Real (Simple) Reason Chinese Stocks Have Resumed Their Fall

The Shanghai Composite looked like it might rebound, but Chinese stocks had a chance to show their true colors again today. Take the hint.

Should You Buy Coca-Cola Stock? 3 Pros, 3 Cons (KO)

Coca-Cola stock is attractive to long-term investors, but that doesn't mean KO is without a few downsides.

Facebook Earnings: What to Know Before Wednesday’s Report (FB)

FB stock has been one of the best -- if not the best -- growth stocks for the past couple of years.

Why Capital One Financial Corp. (COF), Biogen Inc. (BIIB) and Tripadvisor Inc. (TRIP) Are 3 of Today’s Worst Stocks

Capital One Financial (COF), Biogen (BIIB) and Tripadvisor (TRIP) couldn't win for losing on Friday -- mostly thanks to earnings.